Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, J Van Lunzen, ... Jama 316 (2), 171-181, 2016 | 1787 | 2016 |
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection A Ammassari, R Murri, P Pezzotti, MP Trotta, L Ravasio, P De Longis, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 28 (5), 445-449, 2001 | 680 | 2001 |
Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature A Ammassari, MP Trotta, R Murri, F Castelli, P Narciso, P Noto, J Vecchiet, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 31, S123-S127, 2002 | 673 | 2002 |
Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons A Ammassari, A Antinori, MS Aloisi, MP Trotta, R Murri, L Bartoli, ... Psychosomatics 45 (5), 394-402, 2004 | 385 | 2004 |
Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy F Starace, A Ammassari, MP Trotta, R Murri, P De Longis, C Izzo, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 31, S136-S139, 2002 | 366 | 2002 |
Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA) A Cingolani, A Antinori, MG Rizzo, R Murri, A Ammassari, F Baldini, ... Aids 16 (3), 369-379, 2002 | 311 | 2002 |
Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays … A Antinori, A Ammassari, A De Luca, A Cingolani, R Murri, G Scoppettuolo, ... Neurology 48 (3), 687-694, 1997 | 292 | 1997 |
Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy A Antinori, A Cingolani, L Alba, A Ammassari, D Serraino, BC Ciancio, ... Aids 15 (12), 1483-1491, 2001 | 278 | 2001 |
Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ... The Journal of infectious diseases 211 (2), 178-186, 2015 | 230 | 2015 |
Patient-reported nonadherence to HAART is related to protease inhibitor levels R Murri, A Ammassari, K Gallicano, A De Luca, A Cingolani, D Jacobson, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 24 (2), 123-128, 2000 | 212 | 2000 |
Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry … A Antinori, A Cingolani, P Lorenzini, ML Giancola, I Uccella, S Bossolasco, ... Journal of neurovirology 9, 47-53, 2003 | 209 | 2003 |
Relationship between HAART adherence and adipose tissue alterations A Ammassari, A Antinori, A Cozzi-Lepri, MP Trotta, G Nasti, AL Ridolfo, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 31, S140-S144, 2002 | 203 | 2002 |
Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS … A Antinori, G De Rossi, A Ammassari, A Cingolani, R Murri, D Di Giuda, ... Journal of clinical oncology 17 (2), 554-554, 1999 | 189 | 1999 |
Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection M Spina, J Gabarre, G Rossi, M Fasan, C Schiantarelli, E Nigra, M Mena, ... Blood, The Journal of the American Society of Hematology 100 (6), 1984-1988, 2002 | 187 | 2002 |
Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure A Antinori, M Zaccarelli, A Cingolani, F Forbici, MG Rizzo, MP Trotta, ... AIDS research and human retroviruses 18 (12), 835-838, 2002 | 185 | 2002 |
Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy A Antinori, D Larussa, A Cingolani, P Lorenzini, S Bossolasco, MG Finazzi, ... Clinical infectious diseases 39 (11), 1681-1691, 2004 | 175 | 2004 |
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis A De Luca, A Ammassari, P Pezzotti, P Cinque, J Gasnault, J Berenguer, ... Aids 22 (14), 1759-1767, 2008 | 171 | 2008 |
AIDS-related focal brain lesions in the era of highly active antiretroviral therapy A Ammassari, A Cingolani, P Pezzotti, A De Luca, R Murri, ML Giancola, ... Neurology 55 (8), 1194-1200, 2000 | 159 | 2000 |
Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent … A Marzocchetti, S Di Giambenedetto, A Cingolani, A Ammassari, R Cauda, ... Journal of clinical microbiology 43 (8), 4175-4177, 2005 | 154 | 2005 |
Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma A Cingolani, A De Luca, A Ammassari, A Antinori, L Ortona, LM Larocca, ... JNCI: Journal of the National Cancer Institute 90 (5), 364-369, 1998 | 149 | 1998 |